PLM-402

N/A

Report date: 2023/03/04 19:34:00
NME

Base Information

Drug NamePLM-402
Drug Alias NamePLM-402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPelemed Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPelemed Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A